Connect 4 Children (C4C) – Paediatric Clinical Research Networks

Published by IRDiRC

C4C Clinical Research Network Network Orphan Drug Research and Drug Development

c4c (connect4children) is a large collaborative European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population.

View this resource Bookmark this resource

How to Plan and Manage a Project

Published by ANU Press

Project Management Research and Drug Development Translational Research

This Research management manual describes the rules and procedures that are required to successfully conduct translational research programmes . Depending on the nature and the complexity of a given project an increasingly complex and thorough project planning is required.

View this resource Bookmark this resource

Regulatory Guide for Translational Research

Published by EATRIS

Early Access Support Regulatory Sciences Research and Drug Development Scientific Guidelines Regulations

Regulatory Database

View this resource Bookmark this resource

Genetherapy.net

Published by GeneTherapy.net

Advanced Therapy Cell Therapy Drug Discovery EMA Gene Editing Tool Gene Therapy Non-Viral Vector Regulation Affairs Research and Drug Development

Web resource for basic and clinical research in Gene Therapy, cell therapy, and genetic vaccines. In addition, it provides an overview of the different international regulations and guidelines associated with clinical Gene Therapy trials.

View this resource Bookmark this resource

The Assay Guidance Manual

Published by NIH

Drug Discovery Guideline Drug Repurposing NCATS NIH Research and Drug Development Small Molecule Target Validation Drug Development

This manual is a comprehensive resource for early drug discovery, providing guidelines for developing therapeutic hypotheses, validating targets and pathways, and establishing proof of concept criteria. It includes analyses of costs at various stages of drug development. The content encompasses critical decision-making points in New Chemical Entity (NCE) development, exploratory Investigational New Drug (IND) processes, and orphan drug designation. Furthermore, it delves into Drug Repurposing and drug delivery technologies, making it an invaluable guide for professionals initiating new drug discovery and development programs.

View this resource Bookmark this resource

European Patients’ Academy (EUPATI) toolbox

Published by IRDiRC

EUPATI Orphan Drug Patient Information Patient Training Research and Drug Development Toolbox Toolkit for Patient

The EUPATI Academy is the only in-depth training program for patient experts so far in EU that lasts 14months.
It includes an on online training program supported with two weeks of F2F training. The Academy is still operated by EPF, providing high quality training in drug development to patient from EMEA.

View this resource Bookmark this resource

EURORDIS’ Community Advisory Boards

Published by IRDiRC

Community Advisory Board Eurordis Medical Research Orphan Drug Development Patient Advocate Patient Information Patient Organisation Rare Disease Research and Drug Development

Patient Community Advisory Boards are groups established and operated by patient advocates. They facilitate discussions in a safe harbour setting and under strict rules, an MOU and CA on the latest developments and challenges related to medical research and procedures in a disease area with the company or body conducting the research. The CAB can cover from preclinical to post marketing topics. The CAB depending on the areas of discussion can invite scientific expert to serve as advisors.

View this resource Bookmark this resource

European Reference Networks

Published by IRDiRC

Clinical Collaboration European Reference Network Network Rare Disease Research and Drug Development Research Collaboration

Participating in research provides patients with access to cutting-edge treatments and benefit the population and the health services as a whole by leading to the development of more effective, high quality, cost-efficient treatments and healthcare delivery models. ERNs represent an unicum in the clinical and research worldwide collaborative panorama, indeed 24 ERNs span the over 6000 rare diseases by involving 300 EU HCPs and over 1000 specialized units in 25 EU countries

View this resource Bookmark this resource

European Joint Programme on Rare Diseases

Published by IRDiRC

European Union European Union Joint Programme for Rare Disease Network Research and Drug Development

The European Joint Programme Cofund is an instrument allowing high level strategic organization and performance of research activities in an organized and transversal manner.

View this resource Bookmark this resource

Drug repositioning: a brief overview

Published by JPP

Drug Discovery Drug Repurposing Generic Research and Drug Development

Overview of the drug repositioning benefits both its public health benefits and its commercial value.

View this resource Bookmark this resource

The Innovation Management Toolbox was originally developed through funding from the EJP RD project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825575. The continued development and maintenance of the Toolbox are now supported by the ERDERA partnership, funded under the European Union’s Horizon Europe Research & Innovation programme, grant agreement No. 101156595.

IMT Feedback

Did the IMT help you in finding the resource you needed?